RZLT

Rezolute Inc

• TipRanks·5h ago

  Rezolute provides update on FDA review of sunRIZE study

• Benzinga·6h ago

  Rezolute Said FDA Is Still Reviewing Ersodetug Submission In Congenital Hyperinsulinism; The Company Continues To Await Feedback And Reserves The Ability To Request Formal Meeting Under Regulatory Timeline

• TipRanks·08/25 10:55

  Rezolute: Buy Rating Reaffirmed as FDA Catalysts Support CGM‑Driven Upside, Price Target Maintained at $6

• Benzinga·08/21 14:18

  MARA Holdings, Coinbase Global, Ternium And Other Big Stocks Moving Higher On Friday

• TipRanks·07/29 18:40

  Analysts Offer Insights on Healthcare Companies: Rezolute (RZLT) and Boston Scientific (BSX)

• TipRanks·07/22 15:00

  What the $10B Crinetics Deal & $2.9B Soleno Acquisition Might Say About Palatin’s Rare-Obesity Opportunity

• Benzinga·06/17 11:15

  Rezolute Highlights ENDO Data On Congenital HI Outcomes And Tumor HI Case Series Supporting Ersodetug Program

• Dow Jones·06/15 15:22

  Rezolute Is Maintained at Buy by Guggenheim

• Dow Jones·06/15 15:22

  Rezolute Price Target Raised to $11.00/Share From $6.00 by Guggenheim

• Benzinga·06/15 15:12

  Guggenheim Maintains Buy on Rezolute, Raises Price Target to $11

• TipRanks·06/15 10:41

  Rezolute price target raised to $11, named a Best Idea at Guggenheim

• TipRanks·06/15 10:22

  Analysts Offer Insights on Healthcare Companies: Brainsway (BWAY), Rezolute (RZLT) and Invivyd (IVVD)

• TipRanks·06/10 06:00

  Analysts Offer Insights on Healthcare Companies: Rezolute (RZLT) and Vericel (VCEL)

• TipRanks·06/05 03:35

  Craig-Hallum Keeps Their Hold Rating on Rezolute (RZLT)

• Benzinga·06/04 11:35

  Rezolute To Present Four Presentations At Upcoming Annual Meeting Of Endocrine Society